Member Info for EmeraldCarrots

Cwalsh.

Read the last few paragraphs. I still hold by the way.

https://www.lse.co.uk/rns/GDR/sussex-nhs-trust-transitions-mt-rnr1-test-to-bau-gsv4slf8yi9c325.html

If he has bought a load why is the sp down 9.62%. Did he hit sell instead? LOL!

For the 14 Hospital trial, then we wait for the NICE rollout decision early July.

==============

I think the individual hospital trusts will be asked to fund the gap. We know at least 1 has agreed to this so far.

Not an ideal situation and why I sold some @ 1.35p last week.

All IMHO.

For the 14 Hospital trial, then we wait for the NICE rollout decision early July.

All IMHO.

Are one of the main players with an almost unique ability using Parsortix to catch live, intact, uncontaminated CTC's. No wonder Astrazenica have made the Master Services Agreement with us. We are Nr.1 for this in the WORLD. The market is asleep. It's astonishing market players don't seem to be able to understand what is happening NOW!

AI Overview

Demand for analyzing circulating tumor cells (CTCs) in cancer drug trials is surging due to the push for precision oncology. CTCs provide a minimally invasive, real-time "liquid biopsy" that helps pharma and research institutions track drug efficacy, understand tumor heterogeneity, and identify drug resistance.

.

Phase 3 trial. Press release:-

https://investors.immatics.com/news-releases/news-release-details/immatics-presents-clinical-activity-and-response-dynamics-anzu

https://immatics.com/pipeline/

AI Overview

Demand for analyzing circulating tumor cells (CTCs) in cancer drug trials is surging due to the push for precision oncology. CTCs provide a minimally invasive, real-time "liquid biopsy" that helps pharma and research institutions track drug efficacy, understand tumor heterogeneity, and identify drug resistance.

====================

We are going to be very busy.

Marked as ordinary and it's not an uncrossing trade. Seems to be a buy but tomorrow will tell presumably.

Correction.

to send the blood samples in and have the CTC's analysed we will be turning work away in no time. Astra have a couple of hundred cancer drug trials on all the time. What if Myriad Genetics want to use us too.................................... New building needed and another 200 employees! Then what if the immatics phase 3 trial passes and it goes worldwide!!!!!!!!!!!!!! Parsortix is used to select suitable candidates. How many worldwide would that be then????????? Erm??????????100,000??

All IMHO.

To send the blood samples in and have the CTC's analysed we will be turning work away in no time. Astra have a couple of hundred cancer drug trials on all the time. What if Myriad Genetics want to use us too.................................... Now building needed and another 200 employees! Then what id the immatics phase 3 trial passes and it goes worldwide!!!!!!!!!!!!!!

All IMHO.

B_Positive

"Shortsighted selling when there's now considerable Astrazeneca RNS releases coming"

====================

Exactly. Cellbxhealth will be on Astrazeneca's worldwide computer system showing what they can do. Astra is 8 thousand four hundred times as big as Cellbxhealth. Also everyone in their cancer research side will already know about Parsortix as it is very well known already. A lot of cancer drug trials will want it.

Thought the world had gone mad.

Want to use us in. Totally obvious - the Master Services agreement must have been done for a reason! Then a revised sales outlook based of, you guessed it increased turnover due to the new agreement. RNS's x 2 on the way............ it is obvious.

All IMHO.

Rumour is the bigger players sell some starting a fall so they can get in just before good news drops.

Pharma Plc (Astrazenica, 8,400 times larger than Cellbxhealth) still has a load of short term holders by the looks! No pleasing some is there? Clearly this agreement has secured the future though. I'm thinking of cashing in one of my pensions to invest more for the future!!!

All IMHO.

Likely now the 2 main good news deals are in the public domain. I bet they want more shares now the Astrazenica deal is confirmed. Sp primed for takeoff. now.

All IMHO.

,

Thinking, even though it's 100% higher than where we are now. Once the Astrazenica cancer drug trial contracts start flowing the sp will skyrocket. I can easily see us involved in 20 or more of these starting in the next 6 months. Could quite easily be far more in fact.

==================

The first one will light the touch paper I think. Astrazenica must have had at least 2 contracts they have already decided to use Parsortix in or they would not have bothered with the "Master Services" agreement of course. I bet it far, far more contracts than that. In the teens.

All IMHO.

Thinking, even though it's 100% higher than where we are now. Once the Astrazenica cancer drug trial contracts start flowing the sp will skyrocket. I can easily see us involved in 20 or more of these starting in the next 6 months. Could quite easily be far more in fact.

All IMHO.